Log in
Enquire now
‌

US Patent 9061021 mRNA for use in treatment of human genetic diseases

Patent 9061021 was granted and assigned to Shire (pharmaceutical company) on June, 2015 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Shire (pharmaceutical company)
Shire (pharmaceutical company)
0
Current Assignee
Shire (pharmaceutical company)
Shire (pharmaceutical company)
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
90610210
Patent Inventor Names
Michael Heartlein0
Braydon Charles Guild0
Frank DeRosa0
Date of Patent
June 23, 2015
0
Patent Application Number
143255940
Date Filed
July 8, 2014
0
Patent Citations Received
‌
US Patent 11951180 Lipid nanoparticle compositions and methods for MRNA delivery
0
‌
US Patent 12121592 Lipid nanoparticle compositions and methods for mRNA delivery
0
‌
US Patent 12102720 Cleavable lipids
0
‌
US Patent 11951179 Lipid nanoparticle compositions and methods for MRNA delivery
0
‌
US Patent 11951181 Lipid nanoparticle compositions and methods for mRNA delivery
0
Patent Primary Examiner
‌
Richard Schnizer
0
Patent abstract

Compositions for modulating the expression of a protein in a target cell comprising at least one RNA molecule which comprises at least one modification conferring stability to the RNA, as well as related methods, are disclosed.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9061021 mRNA for use in treatment of human genetic diseases

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.